Heart failure is the final stage of most heart diseases and, with over 64 million people affected worldwide, is considered a global pandemic. The prevalence is expected to continue to rise. The prevention and treatment of cardiovascular diseases and the early detection of patients suffering from heart failure are essential. Different therapies are available depending on the extent of the reduction in left ventricular ejection fraction (LVEF). Optimal treatment prevents unnecessary admissions to hospital, reduces mortality and improves quality of life. In the following article, we discuss the diagnosis of heart failure and explain the various treatment options for heart failure with reduced LVEF (HFrEF, HFmrEF).
Keyphrases
- heart failure
- ejection fraction
- aortic stenosis
- left ventricular
- cardiac resynchronization therapy
- acute heart failure
- atrial fibrillation
- coronavirus disease
- risk factors
- hypertrophic cardiomyopathy
- acute myocardial infarction
- sars cov
- healthcare
- left atrial
- emergency department
- transcatheter aortic valve replacement
- replacement therapy
- newly diagnosed
- cardiovascular events